A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2004
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488798A1 HIP/PAP polypeptide composition for use in liver regeneration and for the prevention of liver failure
12/22/2004	EP1488788A1 Pharmaceutical combinations and their use in treating gastrointestinal disorders
12/22/2004	EP1487968A1 Methods of inducing differentiation of stem cells into a specific cell lineage
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487855A2 Method of using modified oligonucleotides for hepatic delivery
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487831A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487829A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487818A1 Alkylammonium salts of omeprazole and esomeprazole
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487540A2 Storage stable eplerenone formulation
12/22/2004	EP1487539A1 Lower esophagus tissue modifier
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487474A2 Intranasal administration of mc4-r agonists
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1487466A1 Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies
12/22/2004	EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1487437A1 Methods of treatment with selective ep4 receptor agonists
12/22/2004	EP1487421A2 Pharmaceutical formulation for the active ingredient budesonide
12/22/2004	EP1487406A1 Heat-reversible composition treating hyposalia and asialia
12/22/2004	EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements
12/22/2004	EP1453949A4 Production of cell suspensions
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1355635B1 New film coating
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	EP0927030B1 Use of aryl n-substituted carboxamides to kill tumors
12/22/2004	CN1556853A Probiotics lactobacillus casei bacterial strain
12/22/2004	CN1556816A Application of cardiokinetic hormone in liver disease
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2004	CN1556716A Modular infusion device and method
12/22/2004	CN1556706A Thieno [1,3] oxazin-4-ones with lipase inhibiting activity
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1556108A Extraction technology of baicalein, medicinal composition and preparation technology of medicine
12/22/2004	CN1556101A Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine
12/22/2004	CN1555889A Cellar air health care therapeutic agent
12/22/2004	CN1555888A Medicinal tablet or capsule for treating digestive ulcer
12/22/2004	CN1555884A Chinese medicinal nourishing product
12/22/2004	CN1555883A Velvet blood body buileing life prolonging health care liquid
12/22/2004	CN1555878A Oral cuvity convalescence liquid
12/22/2004	CN1555872A Medicine for boosting qi, strengthening spleen and nourishing liver and kidney and its preparation method
12/22/2004	CN1555870A Stomach noriising kidney supplementing bacteria and production method
12/22/2004	CN1555869A Preparation technology and use of Chinese herbal medicine phoenix-tail fern
12/22/2004	CN1555860A Medicine for treating hemorrhoids and fistulas
12/22/2004	CN1555858A Chinese medicine for treating virus hepatitis and its preparation method
12/22/2004	CN1555856A Musk willow flower distillate and its preparaton method
12/22/2004	CN1555849A Intestine moistening oral liquid and its preparation method
12/22/2004	CN1555842A Chinese medicine for expelling stasis
12/22/2004	CN1555835A Medicinal pillow, health protection medicinal wine
12/22/2004	CN1555833A Medicine for treating liver disease and its preparation method
12/22/2004	CN1555827A Gall stone expelling and dissolving liquid
12/22/2004	CN1555823A Liver medicinal powder
12/22/2004	CN1555821A Gallbladder pill
12/22/2004	CN1555819A Compound for mula preparation for treating chronic hepatitis B virus and its preparation method
12/22/2004	CN1555811A Pearl lozenge
12/22/2004	CN1555795A Ondansijiong hydrochleride freeze dried powder ampoule for injection and its preparation method
12/22/2004	CN1555788A Thio pronine transfursion liquid and its preparation method
12/22/2004	CN1555785A Emodin injection preparation and its preparation method
12/22/2004	CN1181179C Health-care wine
12/22/2004	CN1181075C Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
12/22/2004	CN1181070C Urea substituted imidazoquinolines
12/22/2004	CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004	CN1181057C Novel 5-pyrimidine carboxamide derivatives and pharmaceutical compositions containing said derivatives
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/22/2004	CN1180794C Gallbladder and appendix antiphlogistic
12/22/2004	CN1180793C Chinese medicine series for treating hepatitis A and B
12/22/2004	CN1180783C Application of fur seal oil in preparation of medicine for treating acute liver damage
12/22/2004	CN1180775C Compound oral ulcer capsule
12/22/2004	CN1180771C Oral cavity adhesive plaster composition for curing gingival disease, laryngopharyngitis and halitosis
12/22/2004	CN1180725C Multielement calcium-rich liver-protecting sobering up beverage
12/21/2004	US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	US6833365 Such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline; for treating diarrhea in immunodeficient individuals
12/21/2004	US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin
12/21/2004	US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
12/21/2004	US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/21/2004	CA2317604C Matrix metalloprotease inhibitors
12/21/2004	CA2252071C Anti-caries oral compositions
12/16/2004	WO2004108945A2 Oligonucleotide modulation of cell adhesion
12/16/2004	WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
12/16/2004	WO2004108674A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these
12/16/2004	WO2004108156A1 A INTRACUTANEOUS INJECTION COMBINED VACCINE INCLUDED HeVac AND BCG AND ITS PREPARATION METHOD
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004108126A1 Fibric acid derivatives for the treatment of irritable bowel syndrome

1 ... 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 ... 1258